Form 8-K · Current report
TransDigm Group 8-K, filed Sep 28, 2026
- Filed
- CIK
- 0001260221
- Accession no.
- 0001260221-26-000064
Summary
TransDigm Group completed its acquisition of Prince & Izant, previously a portfolio company of Industrial Growth Partners, for approximately $1.066 billion in cash including certain tax benefits, financed with cash on hand. Prince & Izant makes highly engineered brazing alloys and specialty metal components, largely for aerospace and defense end markets, and is expected to generate about $390 million in revenue for calendar 2026.
Key points
- TransDigm funded the acquisition with cash on hand.
- Prince & Izant designs and manufactures brazing alloys and specialty metal components, mainly for aerospace and defense, aeroderivative turbine, and transportation end markets, with majority of revenue from the aftermarket.
- P&I is expected to generate approximately $390 million in revenue for the calendar year ending December 31, 2026, and employs about 220 people across four manufacturing sites.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01. Other Events. On September 28, 2026, TransDigm Group Incorporated (“TransDigm Group”) issued a press release (the “Press Release”) announcing the completion of the acquisition of Prince & Izant (“P&I” or “the Company”), formerly a portfolio company of Industrial Growth Partners, for approximately $1.066 billion in cash, including certain tax benefits. TransDigm Group financed the acquisition of the Company through cash on hand. The entry into the definitive agreement to acquire P&I was previously reported in a Current Report on Form 8-K filed on July 27, 2026. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.